Extended Spectrum β-Lactamase-Mediated Resistance and Antibiogram of Pseudomonas aeruginosa Isolates from Patients Attending Two Public Hospitals in Khartoum, Sudan

Table 2

Antibiotic susceptibilities of the positive ESBL P. aeruginosa isolates.

Antibiotics		ESBL production		X^2, value
		Negative ESBL (n = 28) (%)	Positive ESBL (n = 6) (%)
Amikacin	Sensitive	100.0	83.3	4.808, 0.028
	Resistant	0.0	16.7
Meropenem	Sensitive	78.6	100.0	1.561, 0.458
	Intermediate	7.1	0.0
	Resistant	14.3	0.0
Ceftazidime	Sensitive	78.6	0.0	13.357, 0.001
	Resistant	21.4	100.0
Piperacillin	Sensitive	64.3	0.0	8.228, 0.016
	Intermediate	25.0	66.7
	Resistant	10.7	33.3
Ciprofloxacin	Sensitive	75.0	33.3	4.478, 0.107
	Intermediate	10.7	16.7
	Resistant	14.3	50.0